Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2023 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cel
... Analysis & Forecast to 2023 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors Read More
-
Hair Loss Treatment & Removal in the US - Industry Market Research Report
... services from purely cosmetic, discretionary treatments to procedures deemed necessary for general personal upkeep. Aging males seeking hair loss treatment and females seeking hair removal services dominate industry demand. Market saturation is expected to be ... Read More
-
Infectious Disease Testing Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics - Latest Microbiology Analyzers and Strategic Profiles of Leading Suppliers
... testing, including their operating characteristics, features and selling prices. The report also presents strategic assessments of leading microbiology market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, ... Read More
-
Tumor Markers Testing Instrumentation: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
... The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 119 ... Read More
-
Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
... for tumor marker testing. Contains 25 pages Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. Read More
-
Hematology and Flow Cytometry Instrumentation: Latest Analyzers and Strategic Profiles of Leading Suppliers
... strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 65 pages Please ... Read More
-
PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review
... to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling ... Read More
-
Emerging Cancer Diagnostic Technologies and Market Applications
... diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages Please note: The delivery time for the electronic version of this report is ... Read More
-
Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers
... potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. The report also presents strategic assessments of current and emerging suppliers of ... Read More
-
Cancer Diagnostic Instrumentation: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers
... The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains ... Read More
-
Franz Haniel & Cie. GmbH - Strategic SWOT Analysis Review
... the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors ... Read More
-
Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Vietnam Pharmaceuticals & Healthcare Q1 2020
... schemes, andauthorities' support for pharmaceutical investment are just some of the factors that would provide a fertile ground for substantialvolume and value growth. However, this potential will mostly attract generic drug companies, given the low ... Read More
-
Allergists in the US - Industry Market Research Report
... patients with less severe allergies may be more likely to put off visiting an industry doctor if other factors stand in the way, such as lack of insurance coverage. Therefore, as insurance coverage has grown ... Read More
-
Cuba Pharmaceuticals & Healthcare Q1 2020
... into commercial opportunities fordrugmakers in the long term, a poor intellectual property environment with limited respect for patents and a strong domesticpharmaceutical industry weaken prospects for innovative drugs sales. Furthermore, emigration and a shrinking working-agepopulation ... Read More
-
Lithuania Pharmaceuticals & Healthcare Q1 2020
... its small population size and thus, limited growth potential willcontinue to hinder commercial opportunities in its pharmaceutical market. Nevertheless, the wide reimbursement coverageremains a draw for multinationals that operate regionally and bid for government tenders.. Read More
-
Malaysia Pharmaceuticals & Healthcare Q1 2020
... a non-transparent process to issue compulsorylicenses will continue to undermine investment by innovative drugmakers in the country. Furthermore, the Malaysianpharmaceutical market will be faced with a myriad of challenges in Malaysia, including weak intellectual property ... Read More
-
Mexico Pharmaceuticals & Healthcare Q1 2020
... access to healthcare services andmedications through a new public health trust, although the financing for this additional coverage is still not sufficiently clear whilethe transition phase pose downside risk to access to treatment. In response ... Read More
-
Peru Pharmaceuticals & Healthcare Q1 2020
... of listed generic drugs, lacks extensive detailsbut has already faced opposition from industry. Despite the government’s increased commitment to the health sector, a weakeconomic outlook and political uncertainty will limit external and internal investment in ... Read More
-
Puerto Rico Pharmaceuticals & Healthcare Q1 2020
... pressure on the high medicine pricing is becoming moreintense. The financial sustainability of Puerto Rico’s healthcare sector is increasingly under pressure. There are significant economicheadwinds, along with recent political upheavals. Sales of pharmaceuticals and healthcare ... Read More
-
Serbia Pharmaceuticals & Healthcare Q1 2020
... affordability levels, weak access to healthcare and a challenging regulatory environment. However, increasing purchasing poweramid rising real wages along with an ageing population and a rising chronic disease burden will provide long-term growth prospectsfor drugmakers. Read More
-
Spain Pharmaceuticals & Healthcare Q1 2020
... of the generic drug sector and the government’s continuedfocus on cost-containment measures targeting prescription drug expenditure. These trends, along with a subdued economicoutlook, make Spain one of the more challenging markets in Western Europe for ... Read More
-
United Arab Emirates Pharmaceuticals & Healthcare Q1 2020
... of private healthcare coverage and the modernisationof health infrastructure will contribute to drive prescription market growth. Stricter pricing controls, generic drug substitution and anunfavourable demographic profile will cause headwinds to firms over the coming years. Read More
-
Generic Pharmaceutical Manufacturing in Canada - Industry Market Research Report
... average generic drug retail price declined during the past decade. To cut healthcare costs, many provinces and territories have set more stringent price caps for generic drugs, effectively preventing generics from exceeding a set share ... Read More
-
Sri Lanka Pharmaceuticals & Healthcare Q1 2020
... foreshadow an increase in chronic disease burdens. Local drug productionwill continue to gradually increase, with public procurement policies favouring local manufacturers, although small economies ofscale and a challenging regulatory and operating environment will continue to ... Read More
